SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
CARDIOMETABOLIC AND PULMONARY COMPLICATIONS
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
7 of
7
|
A MENDELIAN RANDOMIZATION ANALYSIS OF PROTEIN BIOMARKERS AND CVD IN PERSONS WITH HIV (ABSTRACT
80)
Cavan Reilly
University of Minnesota, Minneapolis, MN, USA
RISKS OF METABOLIC SYNDROME, DIABETES, AND CARDIOVASCULAR DISEASE IN ADVANCE TRIAL (ABSTRACT
81)
Andrew Hill
University of Liverpool, Liverpool, United Kingdom
CYP2B6 GENOTYPE AND WEIGHT-GAIN DIFFERENCES BETWEEN DOLUTEGRAVIR AND EFAVIRENZ (ABSTRACT
82)
Rulan Griesel
University of Cape Town, Cape Town, Western Cape, South Africa
CHANGES IN BODY MASS INDEX AND THE RISK OF CARDIOVASCULAR DISEASE: THE D:A:D STUDY (ABSTRACT
83)
Kathy Petoumenos
The Kirby Institute, UNSW Sydney, Sydney, Australia
LOSARTAN TO REDUCE INFLAMMATION AND FIBROSIS ENDPOINTS IN HIV DISEASE (LIFE-HIV) (ABSTRACT
84)
Jason V Baker
Hennepin Healthcare Research Institute, Minneapolis, MN, USA
EFFECTS OF HIV INFECTION AND IMMUNE REGULATION ON LONGITUDINAL LUNG FUNCTION DECLINE (ABSTRACT
85)
Jing Sun
Johns Hopkins University, Baltimore, MD, USA
AZITHROMYCIN FOR TREATMENT OF HIV-RELATED CHRONIC LUNG DISEASE IN AFRICAN CHILDREN (ABSTRACT
86)
Rashida Abbas Ferrand
London School of Hygiene and Tropical Medicine, London, United Kingdom
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
7 of
7
|
